Drug General Information
Drug ID	D08OHU
Former ID	DNC013093
Drug Name	1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528225]
Structure		Download 2D MOL 3D MOL
Formula	C12H8F6N2
Canonical SMILES	C1=CN(C=N1)CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F
InChI	1S/C12H8F6N2/c13-11(14,15)9-3-8(6-20-2-1-19-7-20)4-10(5-9)12(16,17)18/h1-5,7H,6H2
InChIKey	XITLEILYHLIBPC-UHFFFAOYSA-N
PubChem Compound ID	44414156
Target and Pathway
Target(s)	17 alpha-hydroxylase-C17, 20-lyase	Target Info	Inhibitor	[528225]
BioCyc Pathway	Superpathway of steroid hormone biosynthesis
	Glucocorticoid biosynthesis
	Androgen biosynthesis
KEGG Pathway	Steroid hormone biosynthesis
	Metabolic pathways
	Ovarian steroidogenesis
	Prolactin signaling pathway
PathWhiz Pathway	Androgen and Estrogen Metabolism
	Steroidogenesis
Reactome	Androgen biosynthesis
	Glucocorticoid biosynthesis
	Endogenous sterols
WikiPathways	Metapathway biotransformation
	Steroid Biosynthesis
	Oxidation by Cytochrome P450
	Metabolism of steroid hormones and vitamin D
	Glucocorticoid & Mineralcorticoid Metabolism
	Prostate Cancer
	Phase 1 - Functionalization of compounds
References
Ref 528225	Bioorg Med Chem Lett. 2006 Aug 1;16(15):4011-5. Epub 2006 Jun 5.Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Ref 528225	Bioorg Med Chem Lett. 2006 Aug 1;16(15):4011-5. Epub 2006 Jun 5.Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.